Exodontia and antiplatelet therapy.

Area of Science:

• Oral Surgery
• Cardiology
• Pharmacology

Background:

• Physicians often halt antiplatelet therapy before surgery due to bleeding concerns.
• Discontinuing antiplatelet medication can elevate the risk of thromboembolic events.
• Assessing bleeding risk in patients on antiplatelet therapy undergoing dental procedures is crucial.

Purpose of the Study:

• To evaluate the incidence of prolonged postoperative bleeding after dental extractions in patients continuing antiplatelet therapy.
• To determine if antiplatelet medication needs to be stopped before dental extractions.
• To assess the safety of uninterrupted antiplatelet therapy during dental surgery.

Main Methods:

• A study involving 82 patients undergoing dental extractions, with 57 on antiplatelet therapy (aspirin).
• Patients were divided into three groups: interrupted therapy, continued therapy, and no therapy (control).
• Bleeding and clotting times were measured; statistical analysis (one-way ANOVA) was used to compare groups.

Main Results:

• No patient experienced prolonged or significant postoperative bleeding, regardless of antiplatelet therapy status.
• Mean bleeding times were comparable across groups, with continued therapy showing minimal difference from controls.
• Local hemostasis was effectively achieved in all patients using standard pressure packing.

Conclusions:

• Routine dental extractions are safe for patients on long-term antiplatelet medication.
• Interruption or alteration of antiplatelet therapy is not necessary before dental extractions.
• Patients on antiplatelet therapy do not face an elevated risk of excessive postoperative bleeding during dental procedures.